COMMUNIQUÉ DE PRESSE publié le 06/06/2024 à 12:30, il y a 2 années 2 mois Zomedica Announces Presentation of Compelling TRUFORMA(R) Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference Zomedica Corp. announces research confirming TRUFORMA's superiority in diagnosing feline hyperthyroidism compared to CLIA platforms. Dr. Camille Brassard presents results at ACVIM Forum 2024 Zomedica Corp. TRUFORMA Diagnostic Technology Feline Hyperthyroidism Vet Medicine
COMMUNIQUÉ DE PRESSE publié le 06/06/2024 à 12:00, il y a 2 années 2 mois HDBank, the 1st Vietnamese lender to disclose Sustainability Report and net-zero target Ho Chi Minh City Development Joint Stock Commercial Bank (HDBank) releases Sustainability Report, committing to net-zero emissions. Report follows Global Reporting Initiative standards and emphasizes ESG strategies, objectives, and achievements Net-zero Emissions ESG Sustainability Report HDBank Global Reporting Initiative
COMMUNIQUÉ DE PRESSE publié le 06/06/2024 à 11:57, il y a 2 années 2 mois RAPPORT ANNUEL 2023 CAISSE D'EPARGNE LANGUEDOC ROUSSILLON
COMMUNIQUÉ DE PRESSE publié le 06/06/2024 à 11:50, il y a 2 années 2 mois INDUS successfully completes acquisition of British company COLSON X-Cel INDUS Holding AG successfully completes the acquisition of British company COLSON X-Cel, enhancing its internationalization strategy and market presence. The acquisition expands INDUS's portfolio in the industrial engineering sector Acquisition INDUS Holding AG COLSON X-Cel Industrial Engineering Internationalization Strategy
COMMUNIQUÉ DE PRESSE publié le 06/06/2024 à 11:32, il y a 2 années 2 mois Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe Medios AG completes acquisition of Ceban, expanding market position in Europe. Ceban, a pharmaceutical compounding platform, adds strategic diversification and growth opportunities Acquisition Medios AG Pharmaceutical Compounding Ceban Pharmaceuticals B.V. European Market Position
COMMUNIQUÉ DE PRESSE publié le 06/06/2024 à 11:30, il y a 2 années 2 mois Kingfisher Signs Definitive Agreement to Acquire the LGM Project in the Golden Triangle, British Columbia Kingfisher Metals Corp. announces acquisition of LGM Project in the Golden Triangle, British Columbia, expanding its holdings to 630 km2. The project presents significant potential for porphyry Cu-Au mineralization British Columbia Golden Triangle Kingfisher Metals Corp. LGM Project Porphyry Cu-Au Mineralization
COMMUNIQUÉ DE PRESSE publié le 06/06/2024 à 11:00, il y a 2 années 2 mois Money20/20 Europe Unveils Six Incredible Fintech Startups And Industry Disruptors Money20/20 Europe unveils 6 innovative fintech startups at their Startup Media Session in Amsterdam, showcasing the future of money and the transformative potential of these emerging companies in the financial industry Innovation Financial Services Money20/20 Europe Fintech Startups Emerging Companies
COMMUNIQUÉ DE PRESSE publié le 06/06/2024 à 11:00, il y a 2 années 2 mois GoldenPeaks Capital secures senior and junior financing package for solar PV portfolio in Hungary GoldenPeaks Capital secures senior and junior financing package for 64.5 MWp solar PV portfolio in Hungary with Erste Group, Erste Bank Hungary, and Schelcher Prince Gestion. Unique financing structure includes PPAs GoldenPeaks Capital Hungary Erste Group Solar PV Financing Package
COMMUNIQUÉ DE PRESSE publié le 06/06/2024 à 10:53, il y a 2 années 2 mois Valbiotis reaches an agreement to terminate its licensing and supply agreement with Nestlé Health Science Valbiotis regains full ownership of TOTUM•63, a plant-based dietary supplement for prediabetes and early type 2 diabetes, after terminating agreement with Nestlé Health Science Valbiotis Dietary Supplement TOTUM•63 Nestlé Health Science Prediabetes
COMMUNIQUÉ DE PRESSE publié le 06/06/2024 à 10:44, il y a 2 années 2 mois Valbiotis annonce un accord avec Nestlé Health Science actant la fin du contrat de licence et d’approvisionnement Valbiotis annonce la fin de son contrat de licence avec Nestlé Health Science en reprenant la propriété intellectuelle de TOTUM•63, renforçant son portefeuille de produits pour le diabète Valbiotis Propriété Intellectuelle Diabète Contrat De Licence TOTUM 63
Publié le 26/08/2026 à 18:02, il y a 8 heures 42 minutes Altareit: Altarea press release regarding the Primonial matter
Publié le 26/08/2026 à 18:02, il y a 8 heures 42 minutes Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial
Publié le 26/08/2026 à 18:00, il y a 8 heures 45 minutes Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Publié le 26/08/2026 à 18:00, il y a 8 heures 45 minutes Altarea : Conclusion d’un accord global mettant fin au litige entre Altarea et les actionnaires du groupe Praemia (ex-groupe Primonial)
Publié le 26/08/2026 à 18:00, il y a 8 heures 45 minutes KLARSEN : lance Dimea, sa nouvelle activité e-commerce dédiée aux compléments alimentaires
Publié le 27/08/2026 à 02:00, il y a 45 minutes Algo Grande Copper Announces Upsizing of Private Placement
Publié le 27/08/2026 à 00:05, il y a 2 heures 40 minutes Kidoz Reports Record Q2 2026 Revenue, up 37%, as H1 Revenue Reaches US$6.28 Million (CAD$8.66 Million)
Publié le 26/08/2026 à 23:00, il y a 3 heures 45 minutes Datametrex Announces Transition to Semi-Annual Financial Reporting
Publié le 26/08/2026 à 22:30, il y a 4 heures 15 minutes AI/ML Innovations Inc. Closes First Tranche of Private Placement
Publié le 26/08/2026 à 23:05, il y a 3 heures 39 minutes Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
Publié le 26/08/2026 à 18:44, il y a 8 heures AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results
Publié le 26/08/2026 à 18:40, il y a 8 heures 4 minutes MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM
Publié le 26/08/2026 à 18:30, il y a 8 heures 15 minutes Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Publié le 26/08/2026 à 18:00, il y a 8 heures 44 minutes MHM Corporate: reduces the nominal value of its shares to €0.011